WHO issues warnings on fake copies of Novo Nordisk's weight-loss drugs
- The World Health Organization warned against fake Ozempic versions for weight loss, amidst their increasing availability in markets.
- WHO recommended purchasing Ozempic from reliable sources like doctors, cautioning against online or social media vendors.
- WHO advised checking medication packaging for consistency with date stamps as a precautionary measure.
30 Articles
30 Articles
WHO warns of fake Ozempic
The World Health Organization (WHO) issued a medical product alert Thursday warning that fake versions of medications used for diabetes and obesity, like Ozempic, have been detected in some countries. The warning said three fake batches of semaglutide, a type of weight loss drug, were detected in Brazil, the United Kingdom and Northern Ireland in…
WHO issues global alert over fake Ozempic
(NewsNation) — The World Health Organization (WHO) has issued a warning about fake weight loss medication claiming to contain the active ingredients in the diabetes drug Ozempic and weight loss treatment Wegovy. Since 2022, WHO has observed increased reports of falsified semaglutide and other GLP-1 products worldwide; however, this first official notice was issued following confirmation of fake batches in Brazil, the United Kingdom, Northern Ire…
WHO issues global health alert as fake Ozempic drugs containing harmful 'undeclared' ingredients hit the UK
Fake weight Ozempic drugs used to treat weight loss and diabetes are flooding the global market. The World Health Organization has issued a health warning
WHO, Lilly issue warnings about fake weight-loss drugs
Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.
A diabetes drug used for weight loss is so popular that it is almost impossible to get, which has led to the emergence of fraudsters on the market.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium















